Polyrizon Ltd. (PLRZ): R&D Expense
$2.13M
Year ended 2025-12-31
+83.2%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.13M | +299.4% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $534.0K | +60.8% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $332.0K | -4.3% | 2026-03-25, From 2023-01-01 |
| 2022-12-31 | $347.0K | n/a | 2025-03-11, From 2022-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | 2025-12-31 | $2.13M | +299.4% |
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| PolyPid Ltd. (PYPD) | 2025-12-31 | $23.81M | +4.4% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $3.05M | -9.8% |
| INVO Fertility, Inc. (IVF) | 2024-12-31 | $4.9K | -97.1% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $100.0K | 0.0% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $8.38M | -20.8% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
Compare PLRZ, FEMY, PYPD, PMI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗